Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: To construct a prediction model for the risk of depression in the obese population, aiming to facilitate the early identification of high-risk individuals and guide personalized preventive interventions.

Methods: This study was based on the data from the China Health and Retirement Longitudinal Study (CHARLS 2015), the Center for Epidemiologic Studies Depression Scale-10 (CES-D10) to assess the depression of obese patients, Lasso regression and multivariable logistic regression were used to select predictors, the construction of a nomogram model, and the use of the random splitting method divided into a training set ( = 974) and a validation set ( = 418) by the 7:3 method, and the model was evaluated by the ROC curves and the AUC, the H-L goodness-of-fit test, the calibration graphs, and the clinical decision-making curve to assess the model.

Results: A total of 1,392 obese patients were finally included, with a prevalence of depression of 32.68%. Age, respiratory function, renal disease, digestive disease, grip strength, rheumatism and arthritis, and sleep duration were selected to construct the predictive nomogram model of depression risk in obese patients, and the AUCs of the training set and validation set were 0.715 (95% CI = 0.681-0.749) and 0.716 (95% CI = 0.665-0.767). This suggests that the model has moderate discriminatory power. Respectively, the H-L test was statistically insignificant ( > 0.05, H-L test;  > 0.05). Goodness of fit, calibration curves showed significant agreement between the model and actual observations, and clinical decision curves indicated good model calibration and net benefit.

Conclusion: The model constructed in this study has good efficacy in predicting the occurrence of depression in the obese population and can be used for the early identification of high-risk groups and the adoption of targeted preventive measures to reduce the risk of depression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12116313PMC
http://dx.doi.org/10.3389/fpubh.2025.1574386DOI Listing

Publication Analysis

Top Keywords

depression obese
12
obese patients
12
model
9
depression
8
model depression
8
depression risk
8
risk depression
8
obese population
8
early identification
8
identification high-risk
8

Similar Publications

Cardiac rehabilitation programs (CRPs) are multifactorial interventions defined by the World Health Organization as essential strategies to improve patients' health-related quality of life (HRQoL) by enhancing their physical, psychological, social, and occupational well-being. These programs are a cornerstone in the comprehensive treatment of heart disease, facilitating the recovery of functional capacity and reintegration into the workforce through a multidisciplinary approach. The objective of this study was to assess the efficacy of CRPs in enhancing functional capacity (cardiac and psychological) and HRQoL in workers with ischemic heart disease.

View Article and Find Full Text PDF

Potential therapeutic benefits of curcumin in depression or anxiety induced by chronic diseases: a systematic review of mechanistic and clinical evidence.

Front Pharmacol

August 2025

Luzhou Key Laboratory of Traditional Chinese Medicine for Chronic Diseases Jointly Built by Sichuan and Chongqing, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, China.

Introduction: Depression and anxiety are prevalent comorbidities in individuals with chronic diseases, significantly impairing their quality of life and complicating disease management. Curcumin, derived from turmeric (Curcuma longa), has garnered attention for its potential therapeutic benefits in alleviating symptoms of depression and anxiety. However, its specific effects on depressive or anxiety symptoms associated with chronic diseases (DACD) remain unclear.

View Article and Find Full Text PDF

Ever since its discovery, glucagon-like-peptide 1 (GLP-1) and drugs with similar function (collectively GLP-1s) have been used for type 2 diabetes mellitus and have been effective for obesity. Their profound effect on weight loss has resulted in widespread use of these medicines for treating obesity. Extensive studies have shown that GLP-1s decrease body weight, lean mass, and other metabolic phenotypes.

View Article and Find Full Text PDF

Prospective associations of dynapenic abdominal obesity status with distinct trajectories of depressive symptoms: A national cohort study.

Clin Nutr

May 2025

Department of Epidemiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; Department of Clinical Epidemiol

Background And Aims: Dynapenic abdominal obesity has been shown as a risk factor for adverse outcomes. There is no evidence on the longitudinal association of this condition with different courses of depressive symptoms. This study aimed to investigate the association of dynapenic abdominal obesity status with the risk of distinct trajectories of depressive symptoms.

View Article and Find Full Text PDF

Depression outcomes correlated to exposure to per- and poly-fluoroalkyl substances (PFAS).

Environ Sci Pollut Res Int

September 2025

Data Forward Analytics, LLC, Principal, Las Cruces, NM, 88011, USA.

Per- and poly-fluoroalkyl substances (PFAS) are fluorinated organic compounds known as forever chemicals that are used in many materials, from cooking appliances to industrial detergents. Given their high chemical stability due to their lipophilic properties and widespread use, PFAS tend to bioaccumulate in the cardiac, hepatic, renal, gastrointestinal, and neural tissues, resulting in a variety of malignant and non-malignant diseases. Depression is a prevalent mental health condition that affects an individual's activities of daily living.

View Article and Find Full Text PDF